Lam Research Corporation (NASDAQ:LRCX) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Lam Research Corporation (NASDAQ:LRCX) have received a consensus recommendation of “Moderate Buy” from the thirty-five analysts that are presently covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold recommendation, twenty-eight have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $245.35.

LRCX has been the subject of several analyst reports. B. Riley Financial restated a “buy” rating on shares of Lam Research in a research note on Thursday, January 15th. New Street Research boosted their price objective on shares of Lam Research from $195.00 to $235.00 and gave the company a “neutral” rating in a research note on Friday, January 30th. Wells Fargo & Company upped their price objective on shares of Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. Summit Insights upgraded shares of Lam Research from a “hold” rating to a “buy” rating in a research note on Thursday, January 29th. Finally, Mizuho set a $265.00 target price on shares of Lam Research in a report on Wednesday, January 28th.

Lam Research Stock Performance

NASDAQ LRCX opened at $233.31 on Tuesday. The firm has a market cap of $291.35 billion, a P/E ratio of 47.81, a P/E/G ratio of 2.46 and a beta of 1.77. Lam Research has a 52-week low of $56.32 and a 52-week high of $256.68. The business’s 50-day moving average price is $227.18 and its 200 day moving average price is $179.07. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, beating the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The firm had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the prior year, the business earned $0.91 EPS. The firm’s revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, equities research analysts expect that Lam Research will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be given a $0.26 dividend. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. Lam Research’s dividend payout ratio (DPR) is presently 21.31%.

Insider Buying and Selling at Lam Research

In other news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the sale, the director directly owned 253,705 shares of the company’s stock, valued at $57,235,848. This trade represents a 12.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ava Harter sold 1,500 shares of Lam Research stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $222.66, for a total value of $333,990.00. Following the completion of the sale, the insider owned 53,205 shares in the company, valued at approximately $11,846,625.30. This trade represents a 2.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 130,886 shares of company stock valued at $29,658,802. 0.31% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Lam Research

A number of hedge funds and other institutional investors have recently bought and sold shares of LRCX. PMV Capital Advisers LLC purchased a new stake in shares of Lam Research in the fourth quarter valued at about $25,000. Stance Capital LLC purchased a new position in shares of Lam Research during the 3rd quarter worth approximately $26,000. Bayban acquired a new position in shares of Lam Research during the 4th quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new position in shares of Lam Research during the 2nd quarter worth approximately $27,000. Finally, Triumph Capital Management purchased a new stake in Lam Research in the 3rd quarter valued at approximately $27,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.